Figure 5 | Cell Death & Disease

Figure 5

From: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs

Figure 5

Association of PDPK1 and RCC patient survival who underwent targeted therapies in TCGA data set. PDPK1 mRNA expression data (RNA-Seq) of RCC patient underwent targeted therapies in TCGA was retrieved, and the X-tile was used to generate an optimal cutoff point to dichotomize PDPK1 mRNA level as ‘High’ and ‘Low’ using a Monte-Carlo P-value <0.05. The Kaplan–Meier method (log-rank test) was used to analyze patient survival after treatments. Sample size (N), median survival (MS), and hazard ratio (HR) are depicted

Back to article page